Immediate Impact

59 standout
Sub-graph 1 of 22

Citing Papers

Emerging nitric oxide gas‐assisted cancer photothermal treatment
2024 Standout
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
1 intermediate paper

Works of Jorge Darcourt being referenced

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)
2019
Phase ib study of trastuzumab emtansine (TDM1) in combination with lapatinib and nab-paclitaxel in metastatic HER2-neu overexpressed breast cancer patients: Stela results.
2018
and 1 more

Author Peers

Author Last Decade Papers Cites
Jorge Darcourt 210 47 37 497 324 19 900
V. Delcey 83 19 376 291 28 741
Eli Serur 255 45 12 473 113 38 938
Christine Colie 266 18 19 632 159 39 955
Valérie Martinez 233 132 5 343 366 38 999
Lee B. Moskowitz 117 72 19 452 244 28 1.1k
James M. Gulizia 194 44 24 316 119 19 880
Merlin H. Sayers 109 30 4 452 239 16 990
M.N. Peraldi 118 128 61 224 196 36 835
J. L. Ziegler 336 69 16 285 137 18 946
Gerber Ma 74 37 30 483 135 34 858

All Works

Loading papers...

Rankless by CCL
2026